In a previous paper it was reported that membrane immunoglobulin on the surface of normal human B cells may be revealed by applying an immunoperoxidase 'sandwich' to fixed smears of washed cells.' This technique yields permanent preparations which, when examined by routine light microscopy, show a dense peripheral deposit of brown peroxidase reaction product around positive cells, which contrasts clearly with the haematoxylin counterstain. In addition to excellent cytological detail, this method offers the advantage that (since cells are smeared and fixed before exposure to antibody) surface membrane features (eg, villous processes) are preserved. Furthermore, the preliminary smearing and fixation of cells prevents non-specific membrane binding of antibody via its Fc region,2 a phenomenon that is an important cause of non-specific labelling in conventional immunofluorescent procedures. 3 4 In the present paper we report our experience in the application of this immunoperoxidase procedure to the staining of neoplastic cell surface immunoReceived for publication 10 December 1979 globulin in a variety of human B Cells were incubated in Hank's solution containing 0-2 mg/ml trypsin (Worthington Biochemical Corp) for 30 minutes at 370C. They were then washed and cultured in RPMI medium containing 10% fetal calf serum at 370C in 5% CO2 for 6 hours. Cell smears prepared after trypsinisation and after culture were stained by the PAP procedure.
Results
A total of 42 patients suffering from a variety of lymphoproliferative disorders were studied. Details of the positive staining reactions obtained by the immunoperoxidase technique are given in the Table. NON-CLL CASES In each of 14 cases of non-CLL lymphoproliferative disease (hairy cell leukaemia, non-Hodgkin's lymphoma, prolymphocytic leukaemia, B cell acute lymphoblastic leukaemia), positive immunoperoxidase staining for immunoglobulin of the majority of neoplastic cells was detected (Table) . This immunoglobulin was considered to be localised to the surface membrane (see below), and in all but one case (in which an equivocal reaction was obtained) ji chains were detected. Staining for light chains was limited to a single class (with the exception of one case of hairy cell leukaemia in which strong staining for K chains was accompanied by equivocal staining for A chains).
The appearance of the immunoperoxidase reaction in these cases resembled the pattern previously described for IgM on normal human peripheral B cells.1 This characteristically took the form of diffuse weak labelling over the entire cell area (including both cytoplasm and nucleus) associated with a more intense staining of the cell margin, where a villous surface outline was frequently delineated (Figs la, 2a) . However, not all neoplastic lymphoid cells showed this pattern; Fig. 3 illustrates a labelled cell from a case of centrocytic lymphoma which was unusually smooth in outline.
In all the samples studied in this investigation, cellular morphological detail was very easily visualised owing to the good preservation of cell structure by the formalin-containing fixative and the crisp delineation of nuclear detail by the haematoxylin counterstain. A variety of alternative fixatives and counterstains were assessed during the course of this study but none provided better preservation of cellular detail.
Although the appearance ofthe immunoperoxidase staining reaction in the majority of cases suggested that immunoglobulin on the cell surface (rather than within the cytoplasm) was being detected, there were two cases in which the staining pattern was not so obviously localised to the membrane. However, in one of these cases (MF) exposure of cells in suspension to anti-ji antiserum before smearing and staining caused the labelling pattern to be replaced by small localised clumps of staining, while in the other (FG) the surface localisation of the immunoglobulin was inferred from its abolition by exposure of the cells in suspension to trypsin and its reappearance after short-term in vitro culture.
'Capping' experiments with anti-pL or anti-K antiserum to confirm the surface membrane localisation of the immunoglobulin detected by the immunoperoxidase technique were also performed in six other cases, in all of which clear redistribution of the label was observed (Figs lb, 2b) .
CHRONIC LYMPHATIC LEUKAEMIA
Samples from 28 CLL patients were studied. In three cases a membrane-labelling pattern (see above) was observed (Table) . In two of these cases (BV, AS) a monoclonal serum paraprotein was present (of the same heavy and light chain type as the membrane immunoglobulin).
Cells from two other CLL patients (which were negative for surface immunoglobulin) contained fine rod-shaped inclusions (Fig. 4a) of immunoglobulin (1 IgMK, 1 IgMA) which, on electron microscopic examination (Fig. 4b) , showed the characteristic striated appearance previously described by other authors.6
None of the other 23 CLL samples gave clearly positive reactions with any of the anti-Ig antisera.
Discussion
This study demonstrates that surface immunoglobulin on a variety of human neoplastic lymphoid cells, including 'hairy' cells, B lymphoblasts, lymphoma cells, and prolymphocytes, can be visualised by optical microscopy after immunoperoxidase staining of cell smears. The cell surface (rather than intracytoplasmic) localisation of the immunoglobulin demonstrated in this study was inferred from the characteristic peripheral staining pattern, often delineating a villous cell margin, together with the redistribution of staining induced by preliminary exposure of cells to anti-immunoglobulin antibody before smearing.
The fact that surface immunoglobulin on neoplastic human lymphoid cells can be visualised by staining cell smears has not previously been reported. Zidar et al.7 have claimed that cytoplasmic immunoglobulin can be demonstrated within leukaemic hairy cells by immunocytochemical staining of cell smears. However, these authors appear not to have considered the possibility that they were demonstrating the dense surface coat of immunoglobulin carried by hairy cells. Both the method offixation (methanol) and the staining technique (immunofluorescence) would have made it difficult to distinguish surface from cytoplasmic labelling. Immunoperoxidase staining of optimally fixed cell smears, as described above, would have given a clearer idea of the true location of immunoglobulin in these cells, although, even using this technique, it may be necessary to perform capping or trypsinisation techniques (see above) to detect cytoplasmic immunoglobulin within cells which carry large amounts of this material on their surface membrane.
In contrast to the strong labelling of immunoglobulin on cells such as prolymphocytes and B lymphoblasts, most CLL samples gave negative reactions, probably reflecting the lower density of surface immunoglobulin on CLL cells.8-1' Although its limited sensitivity restricts the value of PAP staining of cell smears as a general technique for surface antigen detection the technique possesses several advantages which may recommend it in specific haematological contexts. Principal among these is the excellent morphological detail visible in immunoperoxidase stained preparations (approaching that of a routine Romanovsky stained smear) which greatly aids the correct classification ofpositive cells. This is particularly of use when attempting to identify a minor population of neoplastic cells among a majority of normal cells, for example, in a bone marrow sample. It may be pointed out that the diagnosis and classification of many lymphoproliferative disorders rests upon the haematologist's ability to assess fine details of nuclear and cytoplasmic morphology. The exercise of this skill requires cell preparations that have been optimally fixed and stained. Clearly, immunocytochemical techniques (such as the procedure described above), which preserve cell morphology and allow it to be visualised simultaneously with a label for membrane antigens, offer major advantages to the haematologist. It may be possible in the future to combine a high level of sensitivity with the cytological advantages of immunoperoxidase labelling by incubating cells in suspension with unlabelled antiserum and then washing, smearing, and fixing them before applying the PAP sandwich. This approach avoids the denaturation of surface antigens caused by cell smearing (as may occur in the procedure used in the present paper) and has given good results in this laboratory when applied to the study of human cell surface antigens detected by murine monoclonal antibodies.12 13 In addition to the benefits of optimal cell visualisation, the PAP procedure offers a number of minor advantages such as the fact that cell smears can be stored frozen for prolonged periods before staining and that peroxidase stained preparations can be kept indefinitely without fading. Furthermore, immunoperoxidase staining can be performed on routine EDTA haematological samples (rather than on defibrinated blood), and relatively small numbers of lymphoid cells (a few hundred) are sufficient for staining. It may also be noted that the technique allows internal and membrane immunoglobulin to be simultaneously demonstrated, as illustrated by the two cases of CLL in which intracellular Ig crystals were stained. The authors of a large survey (72 patients) of these inclusions in CLL cells noted that artefacts (eg, small cytoplasmic folds) cause difficulties in the interpretation of immunofluorescent staining.'4 Because of the greater cell detail visible, this is not a problem with the immunoperoxidase technique, which appears to be the method of choice for the study of these accumulations of immunoglobulin. 
